Here are the biggest analyst calls of the day: Disney, Caterpillar, Apple, Foot Locker & more
Here are the biggest calls on Wall Street on Thursday
Market wire
Headlines on the small cap U.S. and Canadian companies we follow, pulled from the wires as they publish. Every story opens at its original source.
Here are the biggest calls on Wall Street on Thursday
Longtime activist investor Carl Icahn is doubtful rate cuts can simply solve the problems facing the economy.
Aerospace and defense stocks are a good entry point into the market amid a confusing macroeconomic landscape, according to J.P. Morgan.
Barrick Gold Corp is looking to sell its Tongon gold mine in the Ivory Coast and is working with Bank of Nova Scotia to identify buyers,...
Asian shares caught the tail of a Wall Street rally on Friday, helped by China's better-than-expected export figures but fresh concerns about Sino-U.S. trade ties are...
A boycott on Japanese goods in South Korea has had an impact on casual clothing chain Uniqlo's sales in the country, the company said on Friday,...
Pricing in a trade war is hard enough, but it's being made even more challenging by having to account for Trump's Twitter feed.
Kraft Heinz Co's net income halved in the first six months the year as the packaged food maker disclosed well over $1 billion in charges and...
Viacom Inc , the owner of MTV, Comedy Central and Nickelodeon cable networks, beat estimates for quarterly revenue and profit on Thursday, as it posted rare...
Buffett's Berkshire Hathaway has lost almost $5 billion this year on its Kraft Heinz stake as the packaged food company's stock continues to fall.
U.S. stocks opened higher on Thursday, as better-than-expected trade data from China and a steadying of its currency offered some comfort to investors rattled by an...
Goldman Sachs downgraded Caterpillar and said it saw production cuts in the North America and China construction equipment markets due to the ongoing U.S.-China trade.
German drugmaker Bayer is paying up to $600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up investment in a promising new medical...